Rockefeller Capital Management L.P.
Position in ELAN — Elanco Animal Health Inc
CIK 1739439
NEW YORK, NY
Position in ELAN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,553,534
+$173,015 QoQ
Shares Held
64,920
+6.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 91.34165126309304.ToString("F0")%
Shared 0.ToString("F0")%
None 8.658348736906962.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $133,569,034 across 49 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
5,103,509 | $51,086,123 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
282,097 | $37,163,457 | |
| 3 | ZTS |
Zoetis Inc.
|
253,206 | $29,931,479 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $8,351,039 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
64,920 | $1,553,534 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,562 | $926,232 | |
| 7 | VTRS |
Viatris Inc
|
59,826 | $808,247 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
47,612 | $659,425 |
All Filings in ELAN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,553,534 | 64,920 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,380,519 | 61,004 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $1,400,233 | 69,525 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,058,062 | 74,094 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $632,110 | 60,201 | Shares | Defined | 2025-05-14 | |
| 2022-12-31 | $22,080 | 1,807 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $1,710,345 | 137,820 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $69,262,588 | 3,528,405 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $94,664,223 | 3,628,372 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $107,395,537 | 3,784,198 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,781,284 | 2,658,554 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $156,382 | 4,508 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $153,846 | 5,224 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $168,777 | 5,503 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $139,677 | 5,001 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $99,763 | 4,651 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $173,275 | 7,739 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||